Status:
COMPLETED
Review of Isolated Hypoganglionosis and Presentation of a New Case Complicated With Sigmoid Volvulus
Lead Sponsor:
Dr. Ersin Arslan Education and Training Hospital
Collaborating Sponsors:
Inonu University
Conditions:
Pathology
Sigmoid Volvulus
Eligibility:
All Genders
Brief Summary
Isolated hypoganglionosis is rare and constitutes 3-5% of all congenital neurological bowel diseases. Since hypoganglionosis is associated with symptoms such as chronic constipation or pseudo-obstruct...
Detailed Description
Isolated hypoganglionosis is rare and constitutes 3-5% of all congenital neurological bowel diseases. Since hypoganglionosis is associated with symptoms such as chronic constipation or pseudo-obstruct...
Eligibility Criteria
Inclusion
- isolated hypoganglionosis
- our case of isolated hypoganglionosis
Exclusion
- hypoganglionosis with Hirschsprung's disease
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 20 2020
Estimated Enrollment :
310 Patients enrolled
Trial Details
Trial ID
NCT04363125
Start Date
January 1 2019
End Date
April 20 2020
Last Update
April 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr. Ersin Arslan Training and Resource Hospital
Gaziantep, Turkey (Türkiye)